New Results
Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathology
Stefan Grathwohl, Emmanuel Quansah, Nazia Maroof, Jennifer A. Steiner, Liz Spycher, Fethallah Benmansour, Gonzalo Duran-Pacheco, Juliane Siebourg-Polster, Krisztina Oroszlan-Szovik, Helga Remy, Markus Haenggi, Marc Stawiski, Matthias Sehlhausen, Pierre Maliver, Andreas Wolfert, Thomas Emrich, Zachary Madaj, Martha L. Escobar Galvis, Christoph Mueller, Annika Herrmann, Patrik Brundin, View ORCID ProfileMarkus Britschgi
doi: https://doi.org/10.1101/505164
Stefan Grathwohl
Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Emmanuel Quansah
Center for Neurodegenerative Science, Van Andel Research Institute, 333 Bostwick Ave. NE, Grand Rapids, MI, USA
Nazia Maroof
Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Jennifer A. Steiner
Center for Neurodegenerative Science, Van Andel Research Institute, 333 Bostwick Ave. NE, Grand Rapids, MI, USA
Liz Spycher
Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Fethallah Benmansour
Roche Pharma Research and Early Development, pREDi, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Gonzalo Duran-Pacheco
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Juliane Siebourg-Polster
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Krisztina Oroszlan-Szovik
Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Helga Remy
Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Markus Haenggi
Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Marc Stawiski
Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Matthias Sehlhausen
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Pierre Maliver
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Andreas Wolfert
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany
Thomas Emrich
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany
Zachary Madaj
Center for Neurodegenerative Science, Van Andel Research Institute, 333 Bostwick Ave. NE, Grand Rapids, MI, USA
Martha L. Escobar Galvis
Center for Neurodegenerative Science, Van Andel Research Institute, 333 Bostwick Ave. NE, Grand Rapids, MI, USA
Christoph Mueller
Institute of Pathology, University of Bern, Murtenstrasse 31, Bern, Switzerland
Annika Herrmann
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland
Patrik Brundin
Center for Neurodegenerative Science, Van Andel Research Institute, 333 Bostwick Ave. NE, Grand Rapids, MI, USA
Markus Britschgi
Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel, Switzerland

- Supplement[supplements/505164_file02.pdf]
Posted March 20, 2019.
Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathology
Stefan Grathwohl, Emmanuel Quansah, Nazia Maroof, Jennifer A. Steiner, Liz Spycher, Fethallah Benmansour, Gonzalo Duran-Pacheco, Juliane Siebourg-Polster, Krisztina Oroszlan-Szovik, Helga Remy, Markus Haenggi, Marc Stawiski, Matthias Sehlhausen, Pierre Maliver, Andreas Wolfert, Thomas Emrich, Zachary Madaj, Martha L. Escobar Galvis, Christoph Mueller, Annika Herrmann, Patrik Brundin, Markus Britschgi
bioRxiv 505164; doi: https://doi.org/10.1101/505164
Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathology
Stefan Grathwohl, Emmanuel Quansah, Nazia Maroof, Jennifer A. Steiner, Liz Spycher, Fethallah Benmansour, Gonzalo Duran-Pacheco, Juliane Siebourg-Polster, Krisztina Oroszlan-Szovik, Helga Remy, Markus Haenggi, Marc Stawiski, Matthias Sehlhausen, Pierre Maliver, Andreas Wolfert, Thomas Emrich, Zachary Madaj, Martha L. Escobar Galvis, Christoph Mueller, Annika Herrmann, Patrik Brundin, Markus Britschgi
bioRxiv 505164; doi: https://doi.org/10.1101/505164
Subject Area
Subject Areas
- Biochemistry (2479)
- Bioengineering (1731)
- Bioinformatics (9670)
- Biophysics (3896)
- Cancer Biology (2968)
- Cell Biology (4189)
- Clinical Trials (135)
- Developmental Biology (2624)
- Ecology (4098)
- Epidemiology (2031)
- Evolutionary Biology (6894)
- Genetics (5204)
- Genomics (6496)
- Immunology (2183)
- Microbiology (6937)
- Molecular Biology (2751)
- Neuroscience (17261)
- Paleontology (126)
- Pathology (425)
- Physiology (1056)
- Plant Biology (2488)
- Synthetic Biology (831)
- Systems Biology (2687)
- Zoology (429)